Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hahn

Showing results (721-730 of 764) with videos related to

Pageof 77
Sort By:
The Journal of Clinical Investigation|December 5, 2017
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2Liying Chen, Gabriela Alexe, Neekesh V Dharia, et al.
JAMA Oncology|July 17, 2015
Rapid Intraoperative Molecular Characterization of GliomaGanesh M Shankar, Joshua M Francis, Mikael L Rinne, et al.
Cell|December 15, 2018
Organoid Modeling of the Tumor Immune MicroenvironmentJames T Neal, Xingnan Li, Junjie Zhu, et al.
Nature Biotechnology|April 19, 2016
Characterizing genomic alterations in cancer by complementary functional associationsJong Wook Kim, Olga B Botvinnik, Omar Abudayyeh, et al.
Nature Communications|June 23, 2016
Integrated genetic and pharmacologic interrogation of rare cancersAndrew L Hong, Yuen-Yi Tseng, Glenn S Cowley, et al.
Nature Genetics|September 6, 2011
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusionAdam J Bass, Michael S Lawrence, Lear E Brace, et al.
Cancer Cell|July 4, 2009
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancerKrishna M Vasudevan, David A Barbie, Michael A Davies, et al.
Nature|October 23, 2009
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A Barbie, Pablo Tamayo, Jesse S Boehm, et al.
Science (New York, N.Y.)|July 24, 2025
A neomorphic protein interface catalyzes covalent inhibition of RAS<sup>G12D</sup> aspartic acid in tumorsCaroline Weller, G Leslie Burnett, Lingyan Jiang, et al.
Nature|November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivationCory M Johannessen, Jesse S Boehm, So Young Kim, et al.
Pageof 77

Showing results (721-730 of 764) with videos related to

Sort By:
Pageof 77
The Journal of Clinical Investigation|December 5, 2017
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2Liying Chen, Gabriela Alexe, Neekesh V Dharia, et al.
JAMA Oncology|July 17, 2015
Rapid Intraoperative Molecular Characterization of GliomaGanesh M Shankar, Joshua M Francis, Mikael L Rinne, et al.
Cell|December 15, 2018
Organoid Modeling of the Tumor Immune MicroenvironmentJames T Neal, Xingnan Li, Junjie Zhu, et al.
Nature Biotechnology|April 19, 2016
Characterizing genomic alterations in cancer by complementary functional associationsJong Wook Kim, Olga B Botvinnik, Omar Abudayyeh, et al.
Nature Communications|June 23, 2016
Integrated genetic and pharmacologic interrogation of rare cancersAndrew L Hong, Yuen-Yi Tseng, Glenn S Cowley, et al.
Nature Genetics|September 6, 2011
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusionAdam J Bass, Michael S Lawrence, Lear E Brace, et al.
Cancer Cell|July 4, 2009
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancerKrishna M Vasudevan, David A Barbie, Michael A Davies, et al.
Nature|October 23, 2009
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A Barbie, Pablo Tamayo, Jesse S Boehm, et al.
Science (New York, N.Y.)|July 24, 2025
A neomorphic protein interface catalyzes covalent inhibition of RAS<sup>G12D</sup> aspartic acid in tumorsCaroline Weller, G Leslie Burnett, Lingyan Jiang, et al.
Nature|November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivationCory M Johannessen, Jesse S Boehm, So Young Kim, et al.
Pageof 77